Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
Arboviral Encephalitis01:25

Arboviral Encephalitis

Arboviral encephalitis refers to brain inflammation caused by arthropod-borne viruses, particularly those transmitted through mosquito vectors. Among these, West Nile virus (WNV), a member of the Flaviviridae family, is a significant public health concern. WNV is an enveloped, positive-sense, single-stranded RNA virus. Human infection typically begins when an infected mosquito introduces the virus into the dermis during feeding. The primary transmission cycle involves birds as amplifying hosts...
Hemorrhagic Stroke l: Introduction01:17

Hemorrhagic Stroke l: Introduction

A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pseudocapsule status combined with pathological parameters predicts prognosis in renal cell carcinoma.

Frontiers in oncology·2026
Same author

A bibliometric analysis of cardioembolic stroke utilizing HistCite Pro, CiteSpace, and VOSviewer.

Medicine·2026
Same author

The role of Dymeclin in chronic unpredictable mild stress-induced depression: maintaining the Golgi apparatus structure and regulating NLRP3 inflammasome activation.

Molecular medicine (Cambridge, Mass.)·2026
Same author

A Prosthetic Hand System by Contralateral-Collaborative Control Based on Multi-task Learning.

IEEE journal of biomedical and health informatics·2026
Same author

Antimicrobial resistance patterns and genomic characterization of Avibacterium paragallinarum isolates collected in China from 2013 to 2021.

BMC microbiology·2026
Same author

Impact of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitor on Immune-Inflammatory Responses in the Acute Phase of Ischemic Stroke.

Journal of inflammation research·2026

Related Experiment Video

Updated: Jun 28, 2026

The Application Of Permanent Middle Cerebral Artery Ligation in the Mouse
08:27

The Application Of Permanent Middle Cerebral Artery Ligation in the Mouse

Published on: July 25, 2011

19.7K

Non-coding RNAs in acute ischemic stroke: from brain to periphery.

Shuo Li1, Zhaohan Xu1, Shiyao Zhang2

  • 1Department of Neurology, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu Province, China.

Neural Regeneration Research
|May 20, 2024
PubMed
Summary

Non-coding RNAs (ncRNAs) show promise as biomarkers and therapeutic targets for acute ischemic stroke. Research highlights their roles in brain damage and immune responses, offering new clinical applications.

More Related Videos

Two-vessel Occlusion Mouse Model of Cerebral Ischemia-reperfusion
07:34

Two-vessel Occlusion Mouse Model of Cerebral Ischemia-reperfusion

Published on: March 1, 2019

11.8K
Author Spotlight: Establishing a Reliable Distal MCA Occlusion Model in Mice for Stroke Research
07:34

Author Spotlight: Establishing a Reliable Distal MCA Occlusion Model in Mice for Stroke Research

Published on: December 15, 2023

1.9K

Related Experiment Videos

Last Updated: Jun 28, 2026

The Application Of Permanent Middle Cerebral Artery Ligation in the Mouse
08:27

The Application Of Permanent Middle Cerebral Artery Ligation in the Mouse

Published on: July 25, 2011

19.7K
Two-vessel Occlusion Mouse Model of Cerebral Ischemia-reperfusion
07:34

Two-vessel Occlusion Mouse Model of Cerebral Ischemia-reperfusion

Published on: March 1, 2019

11.8K
Author Spotlight: Establishing a Reliable Distal MCA Occlusion Model in Mice for Stroke Research
07:34

Author Spotlight: Establishing a Reliable Distal MCA Occlusion Model in Mice for Stroke Research

Published on: December 15, 2023

1.9K

Area of Science:

  • Biochemistry
  • Genetics
  • Neurology

Background:

  • Acute ischemic stroke presents significant morbidity and mortality.
  • Effective biomarkers and therapeutic targets for stroke remain elusive.
  • Advances in gene sequencing reveal non-coding RNAs (ncRNAs) altered in stroke.

Purpose of the Study:

  • To review the roles of ncRNAs in acute ischemic stroke pathology.
  • To explore the potential of ncRNAs as biomarkers for stroke prediction, diagnosis, and prognosis.
  • To highlight ncRNAs as potential therapeutic targets for stroke.

Main Methods:

  • Literature review of studies on ncRNAs in acute ischemic stroke.
  • Analysis of research on ncRNAs in clinical samples and experimental models.
  • Consolidation of findings on microRNAs, long ncRNAs, and circular RNAs.

Main Results:

  • Aberrantly expressed ncRNAs are implicated in stroke-induced brain damage.
  • ncRNAs in peripheral blood show potential as diagnostic and prognostic biomarkers.
  • ncRNAs in immune cells are involved in post-stroke immune responses.

Conclusions:

  • ncRNAs play critical roles in the pathological processes of acute ischemic stroke.
  • ncRNAs offer significant potential as biomarkers for acute ischemic stroke.
  • ncRNAs represent promising therapeutic targets for acute ischemic stroke management.